Axel REE Advances Caladão Project with Focus on De-Risking ISR Pathway for Rare Earths and Gallium
Rimfire Pacific Mining validates historic drilling results at Rabbit Trap scandium project
Tempest Minerals to acquire four epithermal gold projects on New Zealand’s North Island
Market Overview
ASX 200 Index
Which Stocks Benefit from a Uranium Supply Deficit?
Uranium supply deficit could lift shares as Australia leverages domestic reserves and SMRs to secure base-load power.
Australia’s Best (and Worst) Bank
Australia's Bank of Mum and Dad pumps $35b a year into housing, but rising non-performing loans and fairness issues threaten the unofficial lender's future.
The Weekly Finger: CBA PR team dancing in the streets, waving flags etc
CBA faces police probe over a $1bn mortgage-fraud hole, sparking talk of a banking lending overhaul and potential share moves.
US-Iran War: Energy, Gold, and Silver
Oil jumps as US-Iran tensions flare; Hormuz risk, insurers drop cover. Gold, silver and miners rally as a new mining bull market awakens.
Weekly Wrap: A record close and 3.7% month a big thumbs up
ASX 200 finishes at record close, up 3.7% in Feb as BHP profits beat and banks top forecasts; Block rockets on staff cuts; rare-earths rally lifts Lynas/Iluka.
Boss Energy Reports $36.2m Positive Net Cash Flow from Honeymoon Uranium Project
Boss Energy (ASX: BOE) logs $36.2m positive net cash flow from Honeymoon uranium project; six months to Dec lift in uranium sales, lower C1 costs boost outlook.
Weekly Wrap: ASX slips on war fears as earnings beat expectations buoy week
War fears nudge ASX 200 lower despite QBE's 21% profit surge; energy gains lift oil names, tech slumps; Guzman sinks below float.
ANZ Soars and AMP Sinks: Earnings Breakdown
ANZ delivers $1.9b cash profit in Q1, 3bp NIM uplift, and cost discipline driving outperformance as Feb earnings season kicks off (AMP results due).
Axel REE Advances Caladão Project with Focus on De-Risking ISR Pathway for Rare Earths and Gallium
Axel REE (ASX: AXL) advances Caladão with ISR pilot tests in 2026, de-risking REE and gallium and targeting a non-China, low-capex production path.
Rimfire Pacific Mining validates historic drilling results at Rabbit Trap scandium project
Tempest Minerals to acquire four epithermal gold projects on New Zealand’s North Island
Noronex Secures A$1.25M Tranche Payment for Witvlei Project Sale
Noronex (NRX) has received an A$1.25 million tranche payment from the sale of its non-core Witvlei Project, bolstering its treasury and funding ongoing exploration efforts in Namibia and **Bot
Archer Materials is Building a Scalable Path to Commercial Quantum Technology
Archer Materials (ASX: AXE) charts a scalable, semiconductor-ready path to commercial quantum tech with the 12CQ project, targeting a 2026 qubit.
Island Pharma Partners with USAMRIID and Geneva Foundation for Galidesivir under FDA Animal Rule
Island Pharma signs a 3-year CRADA with USAMRIID and Geneva Foundation to fast-track Galidesivir for Marburg under FDA Animal Rule, eyeing NDA.
Bioxyne Boosts FY26 Outlook on Strong Performance and International Growth
Bioxyne lifts FY26 EBITDA guidance to AUD16.5-19m after record H1 FY2026 with AUD31.3m revenue (+149% YoY); expands capacity, enters UK/Germany/LATAM.
Radiopharm Theranostics Doses First Patient in RV-01 Phase 1/2a Trial for Aggressive Cancers
RAD doses first patient in RV-01 Phase 1/2a trial for aggressive cancers, a 177Lu-radiotherapeutic targeting B7-H3, to define dose for future studies.
Archer Materials is Building a Scalable Path to Commercial Quantum Technology
Archer Materials (ASX: AXE) charts a scalable, semiconductor-ready path to commercial quantum tech with the 12CQ project, targeting a 2026 qubit.
Noviqtech subsidiary Coralia advances sustainable infrastructure mission with Data Centres Australia membership
Control Bionics Bolsters European Expansion with German Reimbursement for NeuroNode
Control Bionics (ASX: CBL) secures German reimbursement for NeuroNode, fueling Europe wholesale push and distributor ramp-up amid funding risks.
FBR Boosts Hadrian Homes Scaling Strategy with AMOVEO WaaS Offtake Agreement
FBR inks binding AMOVEO offtake for Hadrian Homes: 5400m2 wall over 24 months, AUD 400k–450k; aims to deliver ~200 homes in 12 months.
Vintage Energy Extends PURE Loan Facility to Support Southern Flank Reinvigoration
Vintage Energy extends $10m PURE loan to Jan 2028, enabling Odin-3 and Vali-4 drilling with $5m SA grant; potential early $3m repayment, cash covenant eased.
Conrad Asia Energy Gets Green Light for Development of Mako Gas Project
Conrad Asia Energy secures FID for US$320m Mako gas project in Indonesia; first gas targeted by end-2027, fully funded with long-term PLN contract.
Omega Oil & Gas Secures H&P Rig for Expanded Taroom Trough Drill Program
Omega Oil & Gas (ASX:OMA) lands premium Helmerich & Payne FlexRig 648 for a fully funded Taroom Trough drill campaign in 2026/27, with mid-2026 results.
Jade Gas Concludes Appraisal Program, Eyes Maiden Reserve Booking
Jade Gas ends TTCBM appraisal in Mongolia, submits Red Lake report and eyes maiden gas reserve booking within a week to unlock PDO and LNG plans.
The Calmer Co Subsidiary Wins $354,000 Grant to Upgrade Fiji Kava Manufacturing Facility
The Calmer Co International subsidiary wins $354k Fiji CADP grant to upgrade Navua kava RTD bottling, boost Pacific supply chain and expand production.
Pure Foods Tasmania Sees Positive Cash Flow and Increased Profit Margins After Business Realignment
ASX: PFT Pure Foods Tasmania posts positive cash flow and rising margins after realignment, with 70% higher Easter orders and expanding retail reach.
OMG Group to Expand PrOATein Ready-to-Drink Range in Woolworths Supermarkets
OMG Group to roll out three new PrOATein RTDs in 943 Woolworths stores from May to June, backed by SANDAI matcha supply, boosting growth prospects.
Bio-Gene Technology Targets March 2027 APVMA Submission for Flavocide as Toxicology Studies Continue
Bio-Gene targets APVMA submission for Flavocide in March 2027 as toxicology studies progress, but faces ongoing cash burn and fundraising risk.
Never Miss a Market Move
Get the latest ASX small-cap news, exclusive CEO interviews, and market insights delivered to your inbox.
Free weekly newsletter. Unsubscribe anytime.
Ceretas secures $1m for breakthrough ultrasound therapy for dementia, eyes potential IPO
Australian MedTech company Ceretas has successfully secured $1 million in seed funding to advance its low-cost, portable and non-invasive ultrasound device aimed at treating dementia and other neurological conditions. This funding positions the company closer to a potential IPO as it progresses through clinical research and regulatory steps. Initial capital raise fuels development The recent […]
Stormeur IPO to expand non-surgical cosmetics empire
Non-surgical cosmetics group Stormeur has launched a $7 million capital raising to fund the opening of four new Cosmetique clinics along Australia’s east coast. The company announced an initial public offering (IPO) last month based on a growth strategy that includes two new clinics in Sydney and two in Melbourne, to be established within 24 […]
ASX anticipates surge of IPOs later in 2024
Australia’s pipeline of initial public offerings (IPOs) is expected to ramp up in the new year thanks to a cyclical market on the rebound. Anticipated listings for the second half of 2024 include companies in the industrials, mining and consumer discretionary sectors such as cars, household appliances, specialty items, luxury goods and leisure. According to […]
Guzman y Gomez sets sights on ASX listing with IPO to fund aggressive expansion
In a bold move set to shake up Australia’s fast food landscape, Mexican-inspired chain Guzman y Gomez (GYG) is preparing to make its debut on the Australian Securities Exchange (ASX). The company’s upcoming initial public offering (IPO) is not just another corporate event—it’s a statement of GYG’s ambition to redefine fast food in this country. […]